Navigation Links
Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
Date:3/1/2013

THOUSAND OAKS, Calif., March 1, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Cowen and Company 33rd Annual  Health Care Conference on Wednesday, March 6, 2013, at the Boston Marriott Copley Place, Boston, Mass., beginning at 9:20 a.m. EST. Arvind Sood , vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss , 805-313-6151 (media)
Eric Hyllengren , 805-447-1060 (investors)

 


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... ... implementation this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are ... now requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from ...
(Date:12/6/2019)... ... December 06, 2019 , ... Plant Life ... Garden Supply LLC (a division of Horticultural Holdings LLC) to recommend Plant Life ... , FFGS is a team of disciplined and energetic plant lovers formally ...
(Date:12/4/2019)... ... December 04, 2019 , ... The Harm Reduction Institute ... Orange County drug and alcohol rehab center and non-profit Intensive outpatient ... team conducted street outreach, trained, and distributed Naloxone amongst members of the own community ...
Breaking Medicine Technology:
(Date:12/14/2019)... (PRWEB) , ... December 14, 2019 , ... For two ... facility comprised of modular buildings. Driving into the parking lot would make you think ... this odd situation is simple. Hurricane Irma devastated the old building and the hospital ...
(Date:12/9/2019)... WASHINGTON (PRWEB) , ... December 09, 2019 , ... ... create efficiencies in health care information exchange and a trusted advisor to the U.S. ... board member to its Board of Directors, election of Officers* as well as the ...
(Date:12/9/2019)... ... December 09, 2019 , ... OCLI, a Spectrum Vision Partners (SVP) managed ... LASIK, Laser Cataract and Ophthalmology practice with experience spanning decades. As part of OCLI, ... their current practice location at 46 Eagle Rock Ave, East Hanover, NJ 07936. ...
(Date:12/8/2019)... ... December 07, 2019 , ... Intelligent.com, a ... Top 55 Best Master of Science in Nursing (MSN) Degree Programs for 2020. ... and universities in the nation. Each program is evaluated based on curriculum quality, ...
(Date:12/6/2019)... Neb. (PRWEB) , ... December 06, 2019 , ... ... and recruiting, has been recognized for excellence in employee learning. The Omaha-based company ... which ranks organizations with the most successful employer-sponsored training and development programs worldwide. ...
Breaking Medicine News(10 mins):